IP Verse

An Inhaler Comprising A Tiotropium-Containing-Composition - EP2800567

The patent EP2800567 was granted to Teva Pharmaceuticals on Sep 27, 2017. The application was originally filed on Dec 12, 2012 under application number EP12805442A. The patent is currently recorded with a legal status of "Revoked".

EP2800567

TEVA PHARMACEUTICALS
Application Number
EP12805442A
Filing Date
Dec 12, 2012
Status
Revoked
Jan 24, 2020
Grant Date
Sep 27, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

M UNITED KINGDOMJun 27, 2018VOSSIUS & PARTNER -
M UNITED KINGDOMJun 27, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB -

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONGB2264238
DESCRIPTIONUS2004018153
DESCRIPTIONWO0193933
DESCRIPTIONWO9209323
INTERNATIONAL-SEARCH-REPORTEP2201934
INTERNATIONAL-SEARCH-REPORTGB2264238
INTERNATIONAL-SEARCH-REPORTUS2004018153
INTERNATIONAL-SEARCH-REPORTWO0193933
OPPOSITIONEP2201934
OPPOSITIONGB2264238
OPPOSITIONUS2004018153
OPPOSITIONWO0193933
OPPOSITIONWO2004054580
OPPOSITIONWO2011061498
OPPOSITIONWO9413262

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- Drug Delivery to the Respiratory Tract, VCH PUBLISHERS, (1987), pages 87 - 88-
DESCRIPTION- M.C. DURHAM, "Tiotropium (Spiriva): a once-daily inhaled anticholinergic for chronic obstructive pulmonary disease", BUMC PROCEEDINGS, (2004), vol. 17, pages 366 - 373-
DESCRIPTION- Pharmaceutics - The Science of Dosage Form Design, CHURCHILL LIVINGSTONE, (2002), page 476-
DESCRIPTION- RENNARD, THE LANCET, (2004), vol. 364, pages 791 - 802-
DESCRIPTION- S.I. RENNARD, THE LANCET, vol. 2004, no. 364, pages 791 - 802-
OPPOSITION- LENNEY J et al., "Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices", Respir Med, (20000000), vol. 94, no. 5, pages 496 - 500, XP055511666-
OPPOSITION- S. P. NEWMAN, "Principles of Metered-Dose Inhaler Design", RESPIRATORY CARE, (20050900), vol. 50, no. 9, pages 1177 - 1188, XP002725674-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents